Hosted on MSN13d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
Hosted on MSN16d
FDA Expands Approval of Esketamine for Depression
The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants, maker Johnson & ...
Medical News Today11d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
The American Journal of Managed Care16d
Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression
Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD) with inadequate response to at least 2 oral antidepressants.
Newsweek16d
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration (FDA) has approved ... struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients ...
KALW16d
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
Popular Science16d
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first ... by extension esketamine) helps many patients with treatment-resistant depression, researchers still aren’t sure how it ...
MedPage Today17d
FDA Expands Approval of Esketamine for Depression
Opens in a new tab or window The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral ...
Medindia9d
FDA Approves Esketamine Nasal Spray for Resistant Depression
This decision expands the indication of esketamine, offering new hope for patients with treatment-resistant depression(1 Trusted Source FDA approves new nasal spray medication for treatment ...
AOL11d
FDA-approved nasal spray for severe depression can lead to remission
“Over the past 20 years, we’ve been losing the battle to depression ... esketamine versus ketamine, and whether esketamine is as effective as regular ketamine. “Hopefully, this approval by ...
Medical Xpress16d
FDA approves nasal spray for treatment-resistant depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living ... Approval of ...